CD47 and neoplasm: This study hypothesized that blocking the “don’t eat me” anti-macrophage phagocytic signaling with anti-CD47 Ab and activating the “eat me” macrophage phagocytic signaling with anti-CTLA4 Ab could enhance anti-tumor efficacy.